ABBOTINDIA - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.2
✅ Positive
The stock exhibits a relatively stable trend over the past quarter with consistent PAT growth, supported by healthy profitability metrics such as ROCE and ROE. The dividend yield of 1.89% provides additional appeal to investors.
⚠️ Limitation
Recent negative news regarding a "Sell" rating from marketsmojo.com coupled with mixed technical indicators suggest potential headwinds and increased volatility. The PEG ratio of 2.16 indicates the stock is potentially overvalued relative to its growth rate.
📉 Company Negative News
Market Mojo’s reports downgraded Abbott India to “Sell”, indicating concerns about the company's future performance which could negatively affect investor sentiment. Another report highlighted shifting technical momentum, implying a potential weakening trend.
📈 Company Positive News
None found
🏭 Industry
The pharmaceutical sector in India is currently experiencing moderate growth driven by increasing healthcare expenditure and government initiatives promoting domestic manufacturing. However, it remains sensitive to regulatory changes and global supply chain disruptions, presenting both opportunities and risks for companies like Abbott India.
🧾 Conclusion
Based on the current price of 27,800 ₹, an optimal entry zone could be between 26,500 ₹ (a key support level identified by recent lows) and 28,200 ₹ (a resistance zone around the 200-day moving average). Exit signals would be triggered by a break below 26,500 ₹ or a sustained move above 28,200 ₹. The stock appears to be consolidating with moderate momentum and warrants cautious observation given the negative news.